News

The voluntary recall affects medicines made by Johnson and Johnson, which markets Tylenol, and Wyeth, which makes Dimetapp and Robitussin. The recall only affects medicines labeled for infants,

The signature of the development contract, along with a consultancy contract signed in parallel, will provide Viropro with product development and licensing revenues of $2.14 million over the

Centers for Disease Control (CDC) refers to chronic fatigue syndrome (CFS) as a ‘disabling disease, as disabling as other severe chronic conditions like multiple sclerosis, COPD (chronic obstructive

Currently, Samaritan has the marketing rights for Amphocil (amphotericin B cholesteryl sulfate) in Greece and Cyprus, and has successfully registered and obtained a price increase for Amphocil in

The program, involving approximately 2,200 chronic renal failure patients, consists of four trials in the US and Europe, including two trials in patients on dialysis and two trials

Deforolimus is designed to prevent restenosis of injured vessels following interventions in which stents are used in conjunction with balloon angioplasty. As part of the agreement, Ariad will

Zingo provides fast-acting topical, local analgesia, to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children three to 18 years

The collaboration aims to combine the malaria drug data and informatics technology of Collaborative Drug Discovery with the drug discovery expertise of the St. Jude department of chemical

Thelin is the first selective endothelin A receptor antagonist, in the form of 100mg once-daily oral tablets. Thelin is indicated for improving exercise capacity in pulmonary arterial hypertension